Streetbeat News

Stock Prices

AMAT

Over the past 5 years, Applied Materials (NASDAQ:AMAT) has outperformed the market with an annualized return of 25.03%, resulting in an average annual return of 37.69%. A $100 investment in AMAT 5 years ago would now be worth $513.54. The company's current market capitalization stands at $166.11 billion.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 2:00 pm

FI

Over the past 15 years, Fiserv (NYSE:FI) has produced an average annual return of 21.06%, outperforming the market by 7.73%. A $100 investment in Fiserv 15 years ago would now be worth $1,822.25. Fiserv's current market capitalization stands at $89.29 billion.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 2:00 pm

ARIS

Aris Water Solutions (NYSE:ARIS) has seen diverse analyst ratings over the last three months, with a shift towards more bullish sentiments in the last 30 days. The average 12-month price target for ARIS is now $13.62, up from $11.67, indicating a 16.71% increase. Analysts from Goldman Sachs, Wells Fargo, Citigroup, and Seaport Global have adjusted their ratings and price targets, reflecting optimism about the company's financial performance, including a significant revenue growth rate of 25.65%, a net margin of 4.09%, and strong ROE and ROA figures. ARIS's market capitalization is below industry averages, but its financial metrics suggest robust health and growth potential.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 2:00 pm

FTI

TechnipFMC (NYSE:FTI) has been analyzed by 4 analysts, showing a shift towards a more bullish outlook with 3 somewhat bullish and 1 indifferent rating. The average 12-month price target is $28.4, down from $28.67. The company, a leading offshore service provider, has seen a 22.62% revenue growth but struggles with below-average net margin and ROE. Its debt-to-equity ratio is below industry average, indicating less reliance on debt.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 2:00 pm

LXRX

Lexicon Pharmaceuticals (NASDAQ:LXRX) reported Q4 earnings, beating estimates with an EPS of $-0.2 against an expected $-0.22. Revenue increased by $674k from the previous year. Despite beating this quarter's estimates, a miss in the last quarter's EPS led to a 9% share price drop the following day. Historical earnings performance shows mixed results over the past quarters.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 2:00 pm

VTYX

Trading of Ventyx Biosciences shares has resumed. This follows a temporary halt, details of which were not provided in the article.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 1:59 pm

LGF/A

LGF/B

Lions Gate Entertainment shares surged following an upgrade by Barrington Research from Market Perform to Outperform, with a new price target set at $12.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 1:58 pm

RKLB

A Reddit post titled 'Rocket Lab Bull Case' has ignited a debate among Redditors about Rocket Lab USA's (NASDAQ:RKLB) potential in the space industry compared to SpaceX. The post highlights Rocket Lab's valuation at $2 billion, its 44 successful launches, and its unique launch pad in New Zealand as key advantages. Despite skepticism regarding its financials and operational challenges, some Redditors see potential for growth, especially with the upcoming Neutron project. The discussion reflects diverse opinions on Rocket Lab's future in the rapidly growing space exploration market.

Portfolio Pulse from Surbhi Jain

March 11, 2024 | 1:57 pm

ABBV

MLTX

MoonLake Immunotherapeutics (NASDAQ:MLTX) reported significant improvements in psoriatic arthritis outcomes from the ARGO trial of Nanobody sonelokimab, surpassing results of AbbVie Inc's (NYSE:ABBV) Humira. MLTX plans to start Phase 3 trials in 2024, with shares up 3%.

Portfolio Pulse from Vandana Singh

March 11, 2024 | 1:56 pm

VTYX

Ventyx Biosciences shares were halted due to a circuit breaker triggered by a significant upside movement, but the stock is currently down by 23.5%.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 1:55 pm